TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice (original) (raw)

• Selkoe, D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23–A31 (1999).
  Article CAS Google Scholar
• Terry, R.D., Katzman, R., Bick, K.L. & Sisodia, S.S. Alzheimer Disease. 2nd edn. (Lippincott Williams & Wilkins, Philadelphia, 1999).
  Google Scholar
• Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523–527 (1995).
  Article CAS Google Scholar
• Hsiao, K. et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99–102 (1996).
  Article CAS Google Scholar
• Sturchler-Pierrat, C. et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 94, 13287–13292 (1997).
  Article CAS Google Scholar
• Nicoll, J.A.R., Roberts, G.W. & Graham, D.I. Apolipoprotein E ɛ4 allele is associated with deposition of amyloid β-protein following head injury. Nature Med. 1, 135–137 (1995).
  Article CAS Google Scholar
• Guo, Z. et al. Head injury and the risk of AD in the MIRAGE study. Neurology 54, 1316–1323 (2000).
  Article CAS Google Scholar
• Zlokovic, B.V. Cerebrovascular transport of Alzheimer's amyloid β and apolipoproteins J and E: Possible anti-amyloidogenic role of the blood-brain barrier. Life Sci. 59, 1483–1497 (1996).
  Article CAS Google Scholar
• Bales, K.R. et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat. Genet. 17, 263–264 (1997).
  Article CAS Google Scholar
• Holtzman, D.M. et al. Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease. J. Clin. Invest. 103, R15–R21 (1999).
  Article CAS Google Scholar
• Frautschy, S.A., Cole, G.M. & Baird, A. Phagocytosis and deposition of vascular β-amyloid in rat brains injected with Alzheimer β-amyloid. Am. J. Pathol. 140, 1389–1399 (1992).
  CAS PubMed Google Scholar
• Qiu, W.Q. et al. Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation. J. Biol. Chem. 273, 32730–32738 (1998).
  Article CAS Google Scholar
• Yan, S.D., Roher, A., Schmidt, A.M. & Stern, D.M. Cellular cofactors for amyloid β-peptide-induced cell stress. Moving from cell culture to in vivo. Am. J. Pathol. 155, 1403–1411 (1999).
  Article CAS Google Scholar
• Schenk, D. et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173–177 (1999).
  Article CAS Google Scholar
• Bard, F. et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Med. 6, 916–919 (2000).
  Article CAS Google Scholar
• Giulian, D. Microglia and the immune pathology of Alzheimer disease. Am. J. Hum. Genet. 65, 13–18 (1999).
  Article CAS Google Scholar
• Frackowiak, J. et al. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce β-amyloid fibrils. Acta Neuropathol. 84, 225–233 (1992).
  Article CAS Google Scholar
• Finch, C.E., Laping, N.J., Morgan, T.E., Nichols, N.R. & Pasinetti, G.M. TGF-β1 is an organizer of responses to neurodegeneration. J. Cell. Biochem. 53, 314–322 (1993).
  Article CAS Google Scholar
• Wyss-Coray, T. et al. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and Alzheimer's disease. Nature 389, 603–606 (1997).
  Article CAS Google Scholar
• Frautschy, S.A., Yang, F., Calderón, L. & Cole, G. M. Rodent models of Alzheimer's disease: Rat Aβ infusion approaches to amyloid deposits. Neurobiol. Aging 17, 311–321 (1996).
  Article CAS Google Scholar
• Flanders, K.C., Ren, R.F. & Lippa, C.F. Transforming growth factor-βs in neurodegenerative disease. Prog. Neurobiol. 54, 71–85 (1998).
  Article CAS Google Scholar
• Akiyama, H. et al. Inflammation and Alzheimer's disease. Neuroinflammation Working Group. Neurobiol. Aging 21, 383–421 (2000).
  Article CAS Google Scholar
• Roberts, A.B. & Sporn, M.B. Transforming growth factor-β, in The Molecular and Cellular Biology of Wound Repair 2nd edn. (ed. Clark, R.A.F.), 275–308 (Plenum, New York, 1996).
  Google Scholar
• Wyss-Coray, T. et al. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1. Am. J. Pathol. 147, 53–67 (1995).
  CAS PubMed Google Scholar
• Wyss-Coray, T., Lin, C., Sanan, D., Mucke, L. & Masliah, E. Chronic overproduction of TGF-β1 in astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am. J. Pathol. 156, 139–150 (2000).
  Article CAS Google Scholar
• Wahl, S.M. Transforming growth factor beta (TGF-β) in inflammation: A cause and a cure. J. Clin. Immunol. 12, 61–74 (1992).
  Article CAS Google Scholar
• Yao, J., Harvath, L., Gilbert, D. & Colton, C. Chemotaxis by a CNS macrophage, the microglia. J. Neurosci. Res. 27, 36–42 (1990).
  Article CAS Google Scholar
• Wyss-Coray, T., Borrow, P., Brooker, M.J. & Mucke, L. Astroglial overproduction of TGF-β1 enhances inflammatory central nervous system disease in transgenic mice. J. Neuroimmunol. 77, 45–50 (1997).
  Article CAS Google Scholar
• Hsia, A. et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA 96, 3228–3233 (1999).
  Article CAS Google Scholar
• Mucke, L. et al. High-level neuronal expression of Aβ1–42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J. Neurosci. 20, 4050–4058 (2000).
  Article CAS Google Scholar
• Barelli, H. et al. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol. Med. 3, 695–707 (1997).
  Article CAS Google Scholar
• Johnson-Wood, K. et al. Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 1550–1555 (1997).
  Article CAS Google Scholar
• Masliah, E. et al. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16, 5795–5811 (1996).
  Article CAS Google Scholar
• Paxinos, G. The Rat Nervous System. 2nd edn. (Academic, San Diego, 1995).
  Google Scholar
• Mann, D.M. et al. Predominant deposition of amyloid-β 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am. J. Pathol. 148, 1257–1266 (1996).
  CAS PubMed Google Scholar
• Kuo, Y.-M. et al. Comparative analysis of Aβ chemical structure and amyloid plaque morphology of transgenic mice and alzheimer disease brains. J. Biol. Chem. (in the press).
• Weller, R.O. et al. Cerebral amyloid angiopathy. Amyloid β accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am. J. Pathol. 153, 725–733 (1998).
  Article CAS Google Scholar
• Border, W.A. & Noble, N.A. TGF-β in kidney fibrosis: A target for gene therapy. Kidney Int. 51, 1388–1396 (1997).
  Article CAS Google Scholar
• Galbreath, E., Kim, S.-J., Park, K., Brenner, M. & Messing, A. Overexpression of TGF-β1 in the central nervous system of transgenic mice results in hydrocephalus. J. Neuropathol. Exp. Neurol. 54, 339–349 (1995).
  Article CAS Google Scholar
• Kisilevsky, R. Proteoglycans and other basement membrane proteins in amyloidoses. Mol. Neurobiol. 9, 23–24 (1994).
  Article CAS Google Scholar
• Calhoun, M.E. et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc. Natl. Acad. Sci. USA 96, 14088–14093 (1999).
  Article CAS Google Scholar
• Verbeek, M.M., Otte-Höller, I., Veerhuis, R., Ruiter, D.J. & De Waal, R.M.W. Distribution of Aβ-associated proteins in cerebrovascular amyloid of Alzheimer's disease. Acta. Neuropathol. 96, 628–636 (1998).
  Article CAS Google Scholar
• McGeer, P.L. & McGeer, E.G. Inflammation of the brain in Alzheimer's disease: Implications for therapy. J. Leukocyte Biol. 65, 409–415 (1999).
  Article CAS Google Scholar
• Olichney, J.M. et al. The apolipoprotein E4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 47, 190–196 (1996).
  Article CAS Google Scholar